Trial Profile
Single ascending dose study of IMM-01 in cancer patients
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 03 Feb 2016
Price :
$35
*
At a glance
- Drugs IMM 01 (Primary)
- Indications Cancer
- Focus Adverse reactions
- Sponsors TVM Life Science Ventures VII
- 03 Feb 2016 New trial record
- 01 Feb 2016 According to TVM Life Science media release, company is planning to file an Investigational New Drug (IND) application in 2016